TrialJournal for immunotherapy of cancer2020

Phase II study of α-galactosylceramide-pulsed antigen-presenting cells in patients with advanced or recurrent non-small cell lung cancer.

Takahide Toyoda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.